# Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter

> **NCT01900730** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** Valproic Acid (VPA)
- **BEHAVIORAL:** Questionnaires
- **BEHAVIORAL:** Pill Diary
- **BEHAVIORAL:** Drainage Diary

## Key facts

- **NCT ID:** NCT01900730
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07-31
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Due to low accrual
- **Last updated:** 2020-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900730, "Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01900730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*